# C2Sense

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/c2sense

- Industry: Agribusiness
- Headquarters: Cambridge, US
- Website: www.c2sense.com
- Total disclosed funding: $3.6M
- Latest round: Seed (Sep 19, 2017)
- Investors on record: 8

## About

C2Sense, Inc. is a technology company that specializes in developing advanced sensing solutions for environmental monitoring and diagnostic applications, focusing on enhancing accuracy and reliability in detection systems.Founded in 2013 and headquartered in Cambridge, US, C2Sense, Inc. focuses on innovative sensing technologies. The company has secured a total of USD 3.2 mn through its SEED funding round on September 19, 2017, led by Engine Ventures, alongside participation from other investors such as Alumni Ventures Group and Cranberry Capital. The CEO of C2Sense is Jason Cox, and the company was co-founded by Timothy Swager, who has a notable background in scientific innovation.C2Sense, Inc. specializes in advanced diagnostic technologies aimed at enhancing the sensitivity and specificity of point-of-care and at-home testing solutions. The company has developed a suite of diagnostic devices leveraging innovative computer vision and physics-based algorithms, which are designed to improve assay performance by accurately identifying false positives and reducing non-specific binding. Their flagship products include HALO® and HELIOS™, with HALO® focusing on enhancing assay performance without the need for redesign, while HELIOS™ offers a novel approach for multiplex detection of circulating tumor and cell-free DNA. C2Sense serves a diverse client base, including leaders in the healthcare sector, and markets its products across North America, Europe, and parts of Asia, addressing critical needs in both pharmaceutical and nutraceutical sectors.C2Sense generates revenue through strategic partnerships and licensing agreements, enabling the commercialization of its proprietary technologies. Business transactions typically involve B2B structures, collaborating with established players in the diagnostics and pharmaceutical industries to integrate its advanced solutions into their offerings. While specific pricing details for products are not disclosed, revenue streams are bolstered through the sale of diagnostic devices and ongoing support services, emphasizing long-term relationships that foster continuous innovation.C2Sense aims to leverage the recent USD 3.2 mn Seed funding raised in September 2017 to further its research and development initiatives. The company is focused on expanding its product line with enhanced sensing solutions and plans to enter new geographic markets in Asia and Europe by 2025. The funding will support the development of upcoming products designed for environmental monitoring applications, with the goal of increasing market penetration and addressing emerging global needs.

## Funding rounds

- Seed, Sep 19, 2017, $3.2M — Newlin Investment Company, Dream Incubator, Breakout Ventures, Alumni Ventures Group, Cranberry Capital, Propel(x) Inc., Engine Ventures, TLPInvest
- Seed, Oct 6, 2015, $0.3M — Breakout Ventures

## Investors

- Breakout Ventures (https://capitalatlas.ai/funds/breakout-ventures) — Seed
- Newlin Investment Company — Seed
- Dream Incubator (https://capitalatlas.ai/funds/dream-incubator) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- Cranberry Capital (https://capitalatlas.ai/funds/cranberry-capital) — Seed
- Propel(x) Inc. — Seed
- Engine Ventures (https://capitalatlas.ai/funds/engine-ventures) — Seed
- TLPInvest (https://capitalatlas.ai/funds/tlpinvest) — Seed